Axiang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Axiang Li has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Ruyan Gao
State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
6 shared publications - Shupeng Li
State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China
6 shared publications - Zizhen Liu
State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen 518055, China
5 shared publications - Canyu Yang
College of Forensic Medicine, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, People's Republic of China; Institute of Forensic Injury, Institute of Forensic Bio-Evidence, Western China Science and Technology Innovation Harbor, Xi'an Jiaotong University, Xi'an, China; State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China
4 shared publications - Tahir Ali
State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China
4 shared publications - Liufang He
Neonatology Department, The People’s Hospital of Longhua, Shenzhen, China
3 shared publications
Latest Publications
- 24 September 2024
- Published by Elsevier in Neuropharmacology
- Vol. 261, 110156
Ketamine reverses chronic corticosterone-induced behavioral deficits and hippocampal synaptic dysfunction by regulating eIF4E/BDNF signaling
- 24 September 2024
- Published by Elsevier in Neuropharmacology
- Vol. 261, 110156
Ketamine reverses chronic corticosterone-induced behavioral deficits and hippocampal synaptic dysfunction by regulating eIF4E/BDNF signaling
- 10 April 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 132, 111964
NMDAR (2C) deletion in astrocytes relieved LPS-induced neuroinflammation and depression
- 10 April 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 132, 111964
NMDAR (2C) deletion in astrocytes relieved LPS-induced neuroinflammation and depression
- 29 January 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 701, 149550
Ceftriaxone averts neuroinflammation and relieves depressive-like behaviors via GLT-1/TrkB signaling
- 29 January 2024
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 701, 149550
Ceftriaxone averts neuroinflammation and relieves depressive-like behaviors via GLT-1/TrkB signaling
- 7 November 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 961, 176174
A novel dopamine D2 receptor-NR2B protein complex might contribute to morphine use disorders
- 7 November 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 961, 176174
A novel dopamine D2 receptor-NR2B protein complex might contribute to morphine use disorders
- 26 September 2023
- Published by Elsevier in Life Sciences
- Vol. 333, 122102
EPO prevents neuroinflammation and relieves depression via JAK/STAT signaling
- 26 September 2023
- Published by Elsevier in Life Sciences
- Vol. 333, 122102
EPO prevents neuroinflammation and relieves depression via JAK/STAT signaling
- 8 October 2022
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 120, 110655
Neuronal lack of PDE7a disrupted working memory, spatial learning, and memory but facilitated cued fear memory in mice
- 8 October 2022
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 120, 110655
Neuronal lack of PDE7a disrupted working memory, spatial learning, and memory but facilitated cued fear memory in mice